JP2019500380A5 - - Google Patents

Download PDF

Info

Publication number
JP2019500380A5
JP2019500380A5 JP2018533758A JP2018533758A JP2019500380A5 JP 2019500380 A5 JP2019500380 A5 JP 2019500380A5 JP 2018533758 A JP2018533758 A JP 2018533758A JP 2018533758 A JP2018533758 A JP 2018533758A JP 2019500380 A5 JP2019500380 A5 JP 2019500380A5
Authority
JP
Japan
Prior art keywords
compound
optionally substituted
aryl
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018533758A
Other languages
English (en)
Japanese (ja)
Other versions
JP6883913B2 (ja
JP2019500380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/068767 external-priority patent/WO2017117154A1/en
Publication of JP2019500380A publication Critical patent/JP2019500380A/ja
Publication of JP2019500380A5 publication Critical patent/JP2019500380A5/ja
Priority to JP2021078218A priority Critical patent/JP2021121599A/ja
Application granted granted Critical
Publication of JP6883913B2 publication Critical patent/JP6883913B2/ja
Priority to JP2023037940A priority patent/JP2023085300A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018533758A 2015-12-28 2016-12-27 ヒストンデメチラーゼ阻害剤 Expired - Fee Related JP6883913B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021078218A JP2021121599A (ja) 2015-12-28 2021-05-03 ヒストンデメチラーゼ阻害剤
JP2023037940A JP2023085300A (ja) 2015-12-28 2023-03-10 ヒストンデメチラーゼ阻害剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562271654P 2015-12-28 2015-12-28
US62/271,654 2015-12-28
US201662438435P 2016-12-22 2016-12-22
US62/438,435 2016-12-22
PCT/US2016/068767 WO2017117154A1 (en) 2015-12-28 2016-12-27 Histone demethylase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021078218A Division JP2021121599A (ja) 2015-12-28 2021-05-03 ヒストンデメチラーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2019500380A JP2019500380A (ja) 2019-01-10
JP2019500380A5 true JP2019500380A5 (https=) 2020-02-06
JP6883913B2 JP6883913B2 (ja) 2021-06-09

Family

ID=59086937

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018533758A Expired - Fee Related JP6883913B2 (ja) 2015-12-28 2016-12-27 ヒストンデメチラーゼ阻害剤
JP2021078218A Pending JP2021121599A (ja) 2015-12-28 2021-05-03 ヒストンデメチラーゼ阻害剤
JP2023037940A Ceased JP2023085300A (ja) 2015-12-28 2023-03-10 ヒストンデメチラーゼ阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021078218A Pending JP2021121599A (ja) 2015-12-28 2021-05-03 ヒストンデメチラーゼ阻害剤
JP2023037940A Ceased JP2023085300A (ja) 2015-12-28 2023-03-10 ヒストンデメチラーゼ阻害剤

Country Status (6)

Country Link
US (4) US10059687B2 (https=)
EP (1) EP3397617A4 (https=)
JP (3) JP6883913B2 (https=)
CN (1) CN108698997A (https=)
TW (1) TW201722930A (https=)
WO (1) WO2017117154A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397617A4 (en) * 2015-12-28 2019-05-22 Celgene Quanticel Research, Inc. HISTONDEMETHYLASEINHIBITOREN
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
US20200039938A1 (en) 2017-03-30 2020-02-06 Albert-Ludwigs-University Freiburg Kdm4 inhibitors
CN109438339A (zh) * 2018-12-22 2019-03-08 山东大学 Rbp2酶抑制剂小分子化合物wxsa-072a及其制备方法与抗胃癌应用
CN109456262A (zh) * 2018-12-22 2019-03-12 山东大学 基于抑制组蛋白去甲基化酶化合物及其制备方法与抗胃癌应用
AU2020321955A1 (en) 2019-07-30 2022-03-17 Eikonizo Therapapeutics, Inc. HDAC6 inhibitors and uses thereof
IL316201A (en) 2022-04-08 2024-12-01 Eikonizo Therapeutics Inc Oxadiazole HDAC6 inhibitors and their uses
US20240396187A1 (en) 2023-05-24 2024-11-28 Toyota Jidosha Kabushiki Kaisha Secondary battery and battery module

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006070878A1 (ja) * 2004-12-28 2006-07-06 Astellas Pharma Inc. カルボン酸誘導体またはその塩
WO2013143597A1 (en) 2012-03-29 2013-10-03 Glaxo Group Limited Demethylase enzymes inhibitors
RS55764B1 (sr) * 2012-10-02 2017-07-31 Gilead Sciences Inhibitori histonskih demetilaza
US8969343B2 (en) * 2012-12-19 2015-03-03 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
WO2014100818A1 (en) * 2012-12-21 2014-06-26 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
AR100997A1 (es) * 2014-06-25 2016-11-16 Quanticel Pharmaceuticals Inc Derivados de piridina como inhibidores de histona demetilasa
EP3397617A4 (en) 2015-12-28 2019-05-22 Celgene Quanticel Research, Inc. HISTONDEMETHYLASEINHIBITOREN

Similar Documents

Publication Publication Date Title
JP2019500380A5 (https=)
CN113748114A (zh) 一种喹唑啉化合物及其在医药上的应用
CA2863964C (en) Compartmentalized method of nucleic acid delivery and compositions and uses thereof
JP2016536286A5 (https=)
EA201491299A1 (ru) Карбаматные соединения, их получение и применение
EA201691151A1 (ru) Соединения для лечения пациентов с ros1-мутантными раковыми клетками
JP2016508134A5 (https=)
BR212016030926U2 (pt) conjugados de alvo e partículas e formulações dos mesmos
JP2016034978A5 (https=)
JP2016538344A5 (https=)
JP2013509429A5 (https=)
JP2017515901A5 (https=)
JP2016074736A5 (https=)
JP2017518302A5 (https=)
JP2014502641A5 (https=)
JP2016501221A5 (https=)
JP2020097577A5 (https=)
JP2016040288A5 (https=)
JP2017524735A5 (https=)
JP2019515908A5 (https=)
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
BR112014011981A2 (pt) formulações farmacêuticas
NZ721500A (en) Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury
JP2016529285A5 (https=)
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用